In addition, combined MYC and BCL2 immunohistochemistry also identifies ∼20% of DLBCL that show concurrent MYC and BCL2 protein expression, but no evidence of their involvement in translocation. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.